NCT05335668

Brief Summary

Central poststroke pain (CPP) is estimated to affect up to 10% of stroke patients and is one of the most difficult-to-treat conditions with a detrimental effect on patient's quality of life. So far, no drug has proven efficient to alleviate CPP and neuromodulation approaches including Deep Brain Stimulation (DBS) and motor-cortex stimulation have yielded mixed results with only a few patients experiencing long-term pain relief. To date, little is known about the pathophysiology of CPP. There is at present little evidence for a clear association between the specific location of lesions, clinical manifestation and phenomenology of pain as well as treatment response of CPP patients. Furthermore, the time delay between stroke occurrence and CPP occurrence is highly variable and the fact, that it is not immediate in the great majority of patients suggests that other factors contribute to the development of CPP. These factors have not been identified yet.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
16mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jul 2022Sep 2027

First Submitted

Initial submission to the registry

April 12, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 19, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

July 18, 2022

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

4.6 years

First QC Date

April 12, 2022

Last Update Submit

April 30, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation between cerebral connectivity patterns

    Correlation between cerebral connectivity patterns at rest during pain-processing tasks based on functional MRI

    Day 30 after inclusion

Study Arms (3)

Patients with central poststroke pain

EXPERIMENTAL

Patients with central poststroke pain

Procedure: Clinical Testing

Patients without central poststroke pain

EXPERIMENTAL

Patients without central poststroke pain

Procedure: Clinical Testing

healthy controls

ACTIVE COMPARATOR

healthy volunteers

Procedure: Clinical Testing

Interventions

Clinical testing for neurological deficits based on National Institute of Health Stroke Scale (NIHSS), objective sensory testing and pain assessment by quantitative sensory testing (QST) and quantitative pain drawings, 7T magnetic resonance imaging (MRI)

Patients with central poststroke painPatients without central poststroke painhealthy controls

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a haemorrhagic or ischemic stroke affecting the somatosensory system as defined by both CT or MRI and clinical criteria
  • Patient age between 18-75 years
  • Signed written informed consent

You may not qualify if:

  • Secondary stroke due to a cerebral vascular malformation or tumor
  • Patients with aphasic syndromes and impaired verbal communication, complete sensory-motor hemi-neglect and restrictions of the ability to report on their pain and cooperate during sensory testing
  • Patients with severe stroke NIHSS \> 14 and or Modified Rankin Scale (MRS) \> 3
  • History of severe myelopathy or polyneuropathy with clinical sensory deficits and history of neuropathic pain
  • Widespread stroke size due to internal carotid artery-occlusion or more than one main territory (anterior, middle or posterior cerebral artery)
  • Contraindication for 7T MRI (metallic implant, tattoo, claustrophobia, etc.)
  • In case of women \< 45 years of age: pregnancy
  • Informed consent as documented by signature
  • Age: ≥18 years and ≤ 75 years
  • Pregnancy and breastfeeding
  • Contraindication for 7T MRI (metallic implant, tattoo, claustrophobia, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. of Neurosurgery, Bern University Hospital

Bern, 3000, Switzerland

RECRUITING

Related Publications (4)

  • Bowsher D. Central pain: clinical and physiological characteristics. J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):62-9. doi: 10.1136/jnnp.61.1.62.

    PMID: 8676164BACKGROUND
  • Bowsher D, Leijon G, Thuomas KA. Central poststroke pain: correlation of MRI with clinical pain characteristics and sensory abnormalities. Neurology. 1998 Nov;51(5):1352-8. doi: 10.1212/wnl.51.5.1352.

    PMID: 9818859BACKGROUND
  • Karahanoglu FI, Van De Ville D. Transient brain activity disentangles fMRI resting-state dynamics in terms of spatially and temporally overlapping networks. Nat Commun. 2015 Jul 16;6:7751. doi: 10.1038/ncomms8751.

    PMID: 26178017BACKGROUND
  • Preti MG, Bolton TA, Van De Ville D. The dynamic functional connectome: State-of-the-art and perspectives. Neuroimage. 2017 Oct 15;160:41-54. doi: 10.1016/j.neuroimage.2016.12.061. Epub 2016 Dec 26.

    PMID: 28034766BACKGROUND

MeSH Terms

Conditions

Pain

Interventions

Clinical Laboratory Techniques

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Claudio Pollo, MD

    Inselspital Bern, Department of Neurosurgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andreas Nowacki, MD

CONTACT

Claudio Pollo, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2022

First Posted

April 19, 2022

Study Start

July 18, 2022

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations